Search Results - "Prier, Amélie"
-
1
Comparison of bacterial filtration efficiency vs. particle filtration efficiency to assess the performance of non-medical face masks
Published in Scientific reports (24-01-2022)“…As a result of the current COVID-19 pandemic, the use of facemasks has become commonplace. The performance of medical facemasks is assessed using Bacterial…”
Get full text
Journal Article -
2
In platelet single donor apheresis, platelet factor 4 levels correlated with donor’s age and decreased during storage
Published in Scientific reports (14-03-2024)“…The human population is ageing worldwide. The World Health Organization estimated that the world’s population of people aged 60 years and older will increase…”
Get full text
Journal Article -
3
Bioactive lipids as biomarkers of adverse reactions associated with apheresis platelet concentrate transfusion
Published in Frontiers in immunology (17-04-2023)“…Platelet concentrate (PC) transfusion seeks to provide haemostasis in patients presenting severe central thrombocytopenia or severe bleeding. PCs may induce…”
Get full text
Journal Article -
4
Evaluation of in vitro activity of copper gluconate against SARS-CoV-2 using confocal microscopy-based high content screening
Published in Journal of trace elements in medicine and biology (01-12-2021)“…[Display omitted] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that emerged late in 2019 is the etiologic agent of coronavirus disease 2019…”
Get full text
Journal Article -
5
Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology
Published in Frontiers in immunology (07-10-2022)“…Blood products in therapeutic transfusion are now commonly acknowledged to contain biologically active constituents during the processes of preparation. In the…”
Get full text
Journal Article -
6
Lipidomic analysis of differently prepared platelet concentrates in additive solution during storage
Published in Blood transfusion = Trasfusione del sangue (01-09-2023)“…Background: Structural and biochemical changes in stored platelets are influenced by collection and processing methods. Lesions may appear during platelet…”
Get full text
Journal Article -
7
-
8
Platelets as Key Factors in Inflammation: Focus on CD40L/CD40
Published in Frontiers in immunology (03-02-2022)“…Platelets are anucleate cytoplasmic fragments derived from the fragmentation of medullary megakaryocytes. Activated platelets adhere to the damaged endothelium…”
Get full text
Journal Article -
9
Assessment of the soluble proteins HMGB1, CD40L and CD62P during various platelet preparation processes and the storage of platelet concentrates: The BEST collaborative study
Published in Transfusion (Philadelphia, Pa.) (01-01-2023)“…Background Structural and biochemical changes in stored platelets are influenced by collection and processing methods. This international study investigates…”
Get full text
Journal Article -
10
Alteration of microbiota antibody‐mediated immune selection contributes to dysbiosis in inflammatory bowel diseases
Published in EMBO molecular medicine (08-08-2022)“…Human secretory immunoglobulins (SIg) A1 and SIgA2 guide mucosal responses toward tolerance or inflammation, notably through reverse‐transcytosis, the…”
Get full text
Journal Article -
11
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study
Published in EBioMedicine (01-01-2023)“…COVID-19 convalescent plasma (CCP) contains neutralising anti-SARS-CoV-2 antibodies that may be useful as COVID-19 passive immunotherapy in patients at risk of…”
Get full text
Journal Article -
12
The efficacy of therapeutic plasma exchange in COVID-19 patients on endothelial tightness in vitro is hindered by platelet activation
Published in Frontiers in cardiovascular medicine (04-05-2023)“…Coronavirus disease (COVID)-19 is characterised in particular by vascular inflammation with platelet activation and endothelial dysfunction. During the…”
Get full text
Journal Article -
13
-
14
Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology
Published in Frontiers in immunology (07-10-2022)“…Blood products in therapeutic transfusion are now commonly acknowledged to contain biologically active constituents during the processes of preparation. In the…”
Get full text
Journal Article -
15
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study
Published in EBioMedicine (01-01-2023)Get full text
Journal Article -
16
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort studyResearch in context
Published in EBioMedicine (01-01-2023)“…Background: COVID-19 convalescent plasma (CCP) contains neutralising anti-SARS-CoV-2 antibodies that may be useful as COVID-19 passive immunotherapy in…”
Get full text
Journal Article -
17
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study
Published in EBioMedicine (01-01-2023)Get full text
Journal Article -
18
-
19
P-228 Les modèles mathématiques peuvent prédire l[StQuote]activité des plaquettes humaines et les expressions protéiques en réponse à diverses stimulations
Published in Transfusion clinique et biologique : journal de la Société française de transfusion sanguine (01-11-2023)Get full text
Journal Article -
20
Abstract 240: Bioactive Lipids In Circulation: Biomarker Of Ageing?
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2023)“…Abstract only Blood transports cells and nutrients. However, it is less known that the major plasma compound is the lipid family in the broad sense. Among…”
Get full text
Journal Article